The Value of Etoposide for Recurrent Glioma von van der Meulen, Matthijs, Chahal, Manik, Mason, Warren P.

Volltext

Education and training in neurology: developments and future challenges von Meulen, Matthijs, Wijnenga, Maarten M. J.

Volltext

Cognitive functioning and health-related quality of life in patients with newly diagnosed primary CNS lymphoma: a systematic review von van der Meulen, Matthijs, Dirven, Linda, Habets, Esther J J, van den Bent, Martin J, Taphoorn, Martin J B, Bromberg, Jacoline E C

Volltext

SARS-CoV-2 vaccine-related neurological complications von Oonk, Nicol G. M., Ettema, Anne Rozemarijn, van Berghem, Heleen, de Klerk, Jabke J., van der Vegt, Joyce P. M., van der Meulen, Matthijs

Volltext

MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma von van der Meulen, Matthijs, Dirven, Linda, Bakunina, Katerina, van den Bent, Martin J., Issa, Samar, Doorduijn, Jeanette K., Bromberg, Jacoline E. C.

Volltext

COVID-19 and neurological training in Europe: from early challenges to future perspectives von van der Meulen, Matthijs, Kleineberg, Nina N., Schreier, David R., García-Azorin, David, Di Lorenzo, Francesco

Volltext

Primary therapy and survival in patients aged over 70-years-old with primary central nervous system lymphoma: a contemporary, nationwide, population-based study in the Netherlands von van der Meulen, Matthijs, Bromberg, Jacoline E C, Nijland, Marcel, Visser, Otto, Doorduijn, Jeanette K, Dinmohamed, Avinash G

Volltext

The Role of Rituximab in Primary Central Nervous System Lymphoma von Bromberg, Jacoline E. C., van der Meulen, Matthijs, Doorduijn, Jeanette K.

Volltext

Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastoma von van der Meulen, Matthijs, Ramos, Ronald C, Voisin, Mathew R, Patil, Vikas, Wei, Qingxia, Singh, Olivia, Climans, Seth A, Kalidindi, Navya, Or, Rosemarylin, Aldape, Ken, Diamandis, Phedias, Munoz, David G, Zadeh, Gelareh, Mason, Warren P

Volltext

Flow cytometry shows added value in diagnosing lymphoma in brain biopsies von van der Meulen, Matthijs, Bromberg, Jacoline E.C., Lam, King H., Dammers, Ruben, Langerak, Anton W., Doorduijn, Jeanette K., Kros, Johan M., van den Bent, Martin J., van der Velden, Vincent H.J.

Volltext

Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report von van der Meulen, Matthijs, Ramos, Ronald C., Mason, Warren P., Von Deimling, Andreas, Maas, Sybren L.N.

Volltext

Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report von van der Meulen, Matthijs, Ramos, Ronald C., Mason, Warren P., Von Deimling, Andreas, Maas, Sybren L.N.

Volltext

Primary therapy and survival in patients over 70 years old with primary central nervous system lymphoma: a contemporary, nationwide, population-based study in the Netherlands von van der Meulen, Matthijs, Bromberg, Jacoline E.C., Nijland, Marcel, Visser, Otto, Doorduijn, Jeanette K., Dinmohamed, Avinash G.

Volltext

Primary central nervous system lymphoma von de Koning, Myrthe E., Hof, Jurrit J., Jansen, Casper, Doorduijn, Jeanette K., Bromberg, Jacoline E. C., van der Meulen, Matthijs

Volltext

First-line chemotherapeutic treatment for oligodendroglioma, WHO grade 3—PCV or temozolomide? von van der Meulen, Matthijs, Mason, Warren P

Volltext

PATH-28. DIFFERENCES IN METHYLATION PROFILES BETWEEN LONG-TERM SURVIVORS AND SHORT-TERM SURVIVORS OF IDH WILD-TYPE GLIOBLASTOMA von van der Meulen, Matthijs, Ramos, Ronald, Voisin, Mathew, Patil, Vikas, Wei, Qingxia, Singh, Olivia, Climans, Seth, Kalidindi, Navya, Or, Rosamarylin, Diamandis, Phideas, Munoz, David, Zadeh, Gelareh, Mason, Warren

Volltext

Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final Resu... von Bromberg, Jacoline E C, Issa, Samar, van der Holt, Bronno, van der Meulen, Matthijs, Dirven, Linda, Minnema, Monique C, Seute, Tatjana, Durian, Marc, Cull, Gavin, van der Poel, Marjolein W M, Stevens, Wendy B C, Zijlstra, Josee M, Brandsma, Dieta, Nijland, Marcel, Mason, Kylie D, Beeker, Aart, Abrahamse-Testroote, Martine C J, van den Bent, Martin J, de Jong, Daphne, Doorduijn, Jeanette K

Volltext

Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final resu... von Bromberg, Jacoline E C, Issa, Samar, van der Holt, Bronno, van der Meulen, Matthijs, Dirven, Linda, Minnema, Monique C, Seute, Tatjana, Durian, Marc, Cull, Gavin, van der Poel, Marjolein W M, Stevens, Wendy B C, Zijlstra, Josee M, Brandsma, Dieta, Nijland, Marcel, Mason, Kylie D, Beeker, Aart, Abrahamse-Testroote, Martine C J, van den Bent, Martin J, de Jong, Daphne, Doorduijn, Jeanette K

Volltext

Empowering the next generation in neuro-oncology: Introduction of the EANO Career Boost Initiative von Lohmann, Philipp, Duerinck, Johnny, van der Meulen, Matthijs, Mitrea, Dan, Short, Susan, Geurts, Marjolein

Volltext

NCOG-05. IMPACT OF ADDITIONAL RITUXIMAB TO STANDARD THERAPY ON COGNITIVE PERFORMANCES IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS von van der Meulen, Matthijs, Dirven, Linda, Habets, Esther, Bakunina, Katerina, Taphoorn, Martin, van den Bent, Martin, Issa, Samar, Doorduijn, Jeanette K, Bromberg, Jacoline E C

Volltext